Search

everythinglearnresearchcommunity

for

Search:↓

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Adipose-derived stem cells show promise in treating skin conditions like vitiligo, alopecia, and nonhealing wounds.

Three siblings with a genetic form of rickets showed different symptoms of the disease.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.

Mouse stem cells from hair follicles can improve wound healing and reduce scarring.

Softer hydrogels help wounds heal better with less scarring.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

The scalp's microorganisms significantly affect hair health and disease.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.

5-alpha reductase inhibitors may help protect the brain and gut in Parkinson's disease.

Chemotherapy with docetaxel can cause painful nail and skin side effects that may lead to stopping treatment.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Memantine may slightly improve memory in people with Down syndrome, but more research is needed.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Different light affects cell functions and can help treat skin conditions.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

In June 2019, the stem cell research field saw major progress, including new clinical trials, FDA approvals, and industry collaborations.

Skin reactions from cancer treatments might predict how well the treatments work.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

MSC-Exos can aid organ development and offer therapeutic benefits for various conditions.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

The mTurq2-Col4a1 mouse model shows how the basement membrane develops in live mammals.

Gene therapy shows promise for treating skin disorders and cancer, but faces technical challenges.